On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Valo Therapeutics Oy's own share of each project, not the project's full budget.
- Horizon Europe€2.2M · 2 projects
Projects
2 EU-funded projects, newest first. Valo Therapeutics Oy led 1 of them as coordinator. Each links to the official record.
- BRAINSTORMPartner
Wireless deep BRAIN STimulation thrOugh engineeRed Multifunctinal nanomaterials
Horizon Europe · 2023–2027 · Project on CORDIS ↗
- PeptiCHIPCoordinator
Pre-clinical validation and demonstration of PeptiCHIP: an immunopurification microfluidic device and software for (neo)antigen identification and prioritization
Horizon Europe · 2023–2025 · Project on CORDIS ↗
€2.2Mtheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Helsingin YliopistoFinland · 1 shared project
- University of GlasgowUnited Kingdom · 1 shared project
- Friedrich-Alexander-Universitaet Erlangen-NuernbergGermany · 1 shared project
- Universita Degli Studi di Roma Tor VergataItaly · 1 shared project
- ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNESpain · 1 shared project
- Sveuciliste U Zagrebu Fakultet Elektrotehnike i RacunarstvaCroatia · 1 shared project
- Percuros BVNetherlands · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- biomolecules
- coating and films
- nano-materials
- polymer sciences
- ultrasound
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.
